| Literature DB >> 4600903 |
Abstract
In a randomized double-blind controlled trial of the value of intermittent topical idoxuridine in treating herpes zoster in 118 patients idoxuridine 5% in 100% dimethyl sulphoxide (DMSO), applied four-hourly for four days, significantly shortened the vesicular phase, healing time, and duration of pain; idoxuridine 25% applied two-hourly produced no greater benefit. The only side effects were transient tender erythema in three patients and "urticarial" oedema in two patients with dermographia.Entities:
Mesh：
Substances：
Year: 1974 PMID： 4600903 PMCID： PMC1610936 DOI： 10.1136/bmj.2.5918.526
Source DB: PubMed Journal: Br Med J ISSN： 0007-1447